Searchable abstracts of presentations at key conferences in endocrinology

ea0041gp7 | Adrenal | ECE2016

New germline mutation in CACNA1H calcium channel causing primary aldosteronism

Roomp Kirsten , Grzyb Kamil , Wolf Cristina , Rhayem Yara , Oliver Nuria , Wardas Barbara , Beck Andreas , Pico Antonio , Beuschlein Felix , Skupin Alexander , May Patrick , Schneider Jochen G.

Introduction: Primary aldosteronism (PA) occurs due to an excess production of aldosterone in the adrenal glands, resulting in low renin levels and hypertension. Familial hyperaldosteronism is considered to be a relatively rare disorder, with only a small number of genes having been implicated so far. The aim of the present study is to identify the molecular cause of disease in a PA family, as well as examining the mechanisms in an in vitro setting.<p class="abste...

ea0086p332 | Metabolism, Obesity and Diabetes | SFEBES2022

Digital Communication through Covid – A free NHS App for patients with Type 1 diabetes improves accessibility and self-management

Griffin Kirstin , Jabbal Abhimanyu , Turtle Emma

Introduction: Self-management of chronic disease is increasingly being recognised as an essential tool in chronic disease management. During the pandemic, face-to-face diabetes clinics were suspended, and resources were focussed on delivery of urgent care. A free NHS app was created to virtually deliver information on all aspects of type 1 diabetes management and to support patients in their self-management during an increasingly difficult period. The App included an ‘Ale...

ea0021p280 | Pituitary | SFEBES2009

Treatment experience in 11 patients with gigantism

Higham Claire E , Emy Phillipe , Ferone Diego , Finke Reinhard , Laurberg Peter , Main Katharina , Maffei P , Martini C , Minuto Francesco , Rainegard Isabelle , Salzgeber Kirsten , Vogel C , Koltowska-Haggstrom Maria , Trainer Peter J

Gigantism is an extremely rare condition and hence the relevant literature is largely a series of case reports. We present data on patients with gigantism <20 years of age identified from Pfizer’s Acrostudy registry of patients treated with pegvisomant.Eleven patients (5M) were identified: IGF1 at diagnosis was 1.6×ULN (1.15–3.3), height +5 SDS (1.1–3.8) and age 14.5 years (4–19). The three youngest (4, 7 and 14 years) had pi...

ea0015p288 | Reproduction | SFEBES2008

Association of variants within the fat mass and obesity-associated (FTO) gene and polycystic ovary syndrome

Barber Thomas , Bennett Amanda , Groves Christopher , Sovio Ulla , Ruokonen Aimo , Martikainen Hannu , Pouta Anneli , Hartikainen Anna-Liisa , Elliott Paul , Lindgren Cecilia , Freathy Rachel , Koch Kirsten , Ouwehand Willem , Karpe Fredrik , Conway Gerard , Wass John , Jarvelin Marjo-Riitta , Franks Stephen , McCarthy Mark

Background: Obesity plays an important role in the aetiology of polycystic ovary syndrome (PCOS). Variants in the fat-mass and obesity-associated (FTO) gene have recently been shown to influence adiposity and predispose to common obesity (Frayling et al., Science 2007 316 889–894).Aim: Our aim was to establish whether FTO variants are also implicated in PCOS-susceptibility.Methods: A genetic ...

ea0041ep702 | Growth hormone IGF axis - basic | ECE2016

Macronutrient composition has sex specific effects on the GH-IGF-I axis

Kavermann Larissa , Andersen Kirstin , Horngacher Amon , Bidlingmaier Martin

Metabolic diseases are among the most important diseases in western societies and usually related to obesity. Dietary interventions are recommended for treatment and include both strategies with reduced caloric intake and alterations in macronutrient composition. Metabolism must be assumed to be regulated differently in females and males. In previous studies we demonstrated that low carbohydrate high fat (LCHF) diets affect GH/IGF-I axis in male rats. We know investigated whet...

ea0059p172 | Obesity &amp; metabolism | SFEBES2018

Reduced PTEN levels enhance the proliferation as well as differentiation of preadipocytes

Kirstein Anna , Penke Melanie , Kiess Wieland , Garten Antje

Background/aim: Patients with germline mutations in the tumor suppressor PTEN frequently develop single or multiple lipomas. PTEN antagonizes the phosphatidylinositide3-kinase/AKT/mechanistic target of rapamycin (PI3K/AKT/mTOR) pathway, which promotes cell proliferation and is involved in adipocyte differentiation. The aim of this study was to investigate the mechanisms leading to aberrant adipose tissue growth using PTEN knock-down cell models....

ea0041gp52 | Cardiovascular endocrinology | ECE2016

Sex specific effects of alterations in macronutrient composition on fat accumulation, lipid-synthesis, -transport and –storage

Andersen Kirstin , Kavermann Larissa , Horngacher Amon , Tom Robby Zachariah , Sachs Stephan , Hofmann Susanna , Bidlingmaier Martin

Recent data suggest that not only caloric density but also macronutrient composition of diets can influence metabolism, body composition and the development of metabolic disorders. A limitation of previous studies was that effects were studied predominantly in males. To better understand potential differences in the response of males and females to manipulations of dietary macronutrients, our studies were undertaken in both sexes. As a dietary model, we used regular chow diet ...

ea0021p304 | Pituitary | SFEBES2009

Pituitary tumours of mice deleted for a multiple endocrine neoplasia type 1 allele have alterations in apoptotic pathway components

Walls Gerard , Newey Paul , Jeyabalan Jeshmi , Nesbit A Michael , Schulz Herbert , Huebner Norbert , Thakker Rajesh

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by the occurrence of anterior pituitary, pancreatic islet and parathyroid tumours. Mice (Men1+/−) deleted for an MEN1 allele develop these tumours. The MEN1 gene encodes a 610 amino acid protein that has been reported to upregulate caspase 8 expression and promote apoptosis. To characterize the functional effects of menin loss in vivo, we asse...

ea0016p21 | Adrenal | ECE2008

11β-hydroxysteroid dehydrogenase 2 activity is elevated in extreme obese subjects and negatively associated with insulin sensitivity

Mussig Karsten , Remer Thomas , Haupt Axel , Gallwitz Baptist , Fritsche Andreas , Haring Hans-Ulrich , Maser-Gluth Christiane

Objectives: Alterations in glucocorticoid (GC) metabolism may contribute to the development of obesity and insulin resistance. We aimed to study the role of 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) in human adiposity, paying special attention to the association between altered GC metabolism and insulin sensitivity.Design: In 24-h urine samples of 72 extremely obese (mean BMI 45.5±1.1 kg/m2), but otherwise healthy patie...

ea0016p121 | Clinical cases | ECE2008

Primary squamous cell carcinoma of the thyroid

Mussig Karsten , Dahm Julia , Koitschev Assen , Horger Marius , Muller Mark , Bares Roland , Wehrmann Manfred

Background: Primary squamous cell carcinomas of the thyroid are uncommon entities with less than 100 cases described in the literature.Case report: We report on the imaging findings in a rare case of primary squamous cell carcinoma of the thyroid that was found to be the primary tumour of humerus and cervical lymph node metastases. Other sources of squamous cell cancer were ruled out by a careful search, including whole body computed tomography (CT), pos...